ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)
Last Price
33.95
Today's Change
-0.26 (0.76%)
Day's Change
33.36 - 34.25
Trading Volume
280,053
Market Cap
19 Billion
Shares Outstanding
586 Million
Avg Volume
469,465
Avg Price (50 Days)
33.51
Avg Price (200 Days)
28.17
PE Ratio
161.67
EPS
0.21
Earnings Announcement
28-Nov-2024
Previous Close
34.21
Open
34.17
Day's Range
33.36 - 34.25
Year Range
20.03 - 35.76
Trading Volume
280,053
1 Day Change
-0.76%
5 Day Change
1.43%
1 Month Change
1.71%
3 Month Change
14.89%
6 Month Change
30.13%
Ytd Change
53.97%
1 Year Change
71.55%
3 Year Change
10.23%
5 Year Change
75.36%
10 Year Change
595.70%
Max Change
1297.12%
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.